Skip to main content
. 2017 Dec;7(6):499–511. doi: 10.1212/CPJ.0000000000000399

Table 2.

Recommendations for diagnosis of patients identified by molecular genetic screening for NPC1 and NPC2

graphic file with name NEURCLINPRACT2017021501TT2.jpg